Cinclus Pharma Holding AB (publ)

DB:J8P Stock Report

Market Cap: €75.5m

Cinclus Pharma Holding Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:J8P Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
25 Jun 24Buy€2,887Peter UngeIndividual1,000€2.89
20 Jun 24Buy€9,868Anders OhbergIndividual2,635€3.74

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of J8P?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders5,219,52111.2%
Private Companies8,413,27418.1%
Institutions10,105,53621.7%
General Public22,799,45849%

Dilution of Shares: J8P only recently listed within the past 12 months

Top Shareholders

Top 23 shareholders own 51.01% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.48%
Trill Impact Ventures Pharma 1 AB
3,483,125€5.6m0%no data
7.41%
Fourth Swedish National Pension Fund (AP4)
3,448,568€5.6m0%0.02%
6.55%
BidCo af 6. december 2018 AB
3,048,629€4.9m0%no data
5.03%
Movestic Fonder AB
2,341,756€3.8m0%4.15%
4.42%
Linc AB
2,059,122€3.3m0%2.05%
4.35%
Peter Unge
2,022,075€3.3m0%no data
4.1%
Kjell Andersson
1,908,000€3.1m0%no data
4.04%
Estate Of Mikael Dahlström
1,881,520€3.1m0%no data
2.23%
Lennart Hansson
1,037,071€1.7m0%no data
1.93%
Eir Ventures
898,750€1.5m0%100.0%
1.28%
Arctic Asset Management AS
595,000€964.8k0%0.08%
0.86%
AXA Investment Managers S.A.
400,000€648.6k0%no data
0.54%
DNB Asset Management AS
250,000€405.4k0%no data
0.19%
Torbjörn Koivisto
87,285€141.5k0%no data
0.17%
Christer Ahlberg
80,000€129.7k0%no data
0.12%
Clay Asset Management
55,000€89.2k0%0.16%
0.1%
Helena Levander
46,780€75.9k0%no data
0.099%
SEB Investment Management AB
45,924€74.5k51.1%no data
0.045%
Wenche Rolfsen
20,800€33.7k0%no data
0.02%
Anders Ohberg
9,510€15.4k0%no data
0.02%
FCG Fonder AB
9,128€14.8k0%no data
0.017%
Maria Engstrom
8,000€13.0k0%no data
0.0049%
Mercer Global Investments Europe Limited
2,288€3.7k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 04:35
End of Day Share Price 2025/02/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cinclus Pharma Holding AB (publ) is covered by 2 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Oscar Haffen LammBryan Garnier & Co
Kevin SuleRedeye